Immune-Onc Therapeutics, Inc. (“Immune-Onc”) is an early stage biopharmaceutical company focused on developing innovative immunotherapies for cancer treatment. The Company is applying the latest scientific insights and expertise in drug development to advance novel immuno-oncology products and bring new treatment options to cancer patients

CEO: Charlene Liao, Ph.D.

Status: Private

Company Headquarters: Palo Alto, CA